Platinum Investment Management LTD Zymeworks Inc. Transaction History

Platinum Investment Management LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$4.65 - $7.43 $365,052 - $583,299	78,506 Added 26.57%	373,992 $2.3 Million
Q2 2022 Aug 11, 2022	BUY	$4.82 - $7.7 $290,101 - $463,439	60,187 Added 25.58%	295,486 $1.57 Million
Q4 2021 Feb 11, 2022	BUY	$15.19 - $29.33 $1.21 Million - $2.34 Million	79,887 Added 51.4%	235,299 $3.86 Million
Q3 2021 Nov 09, 2021	BUY	$27.35 - $37.28 $1.43 Million - $1.96 Million	52,468 Added 50.97%	155,412 $4.51 Million
Q1 2021 May 13, 2021	BUY	$29.83 - $56.81 $1.51 Million - $2.88 Million	50,617 Added 96.73%	102,944 $3.25 Million
Q1 2020 May 15, 2020	BUY	$24.28 - $49.8 $1.27 Million - $2.61 Million	52,327 New	52,327 $1.86 Million

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $949M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on Platinum Investment Management LTD with notifications on news.